GHDDI is a transformative drug discovery and translational platform with advanced biomedical R&D capabilities - from the bench to the bedside.
Beijing
Joined February 2017
- Tweets288
- Following15
- Followers127
- Likes2
Proud to be one of 14 global contributors to @CEPIvaccines' first-ever global adjuvant library! This $2.5M initiative with 25 adjuvants will accelerate vaccine development for epidemic and pandemic threats. A big step for global health. 🌍💉 #100DaysMission #cepi
📣We’re launching the world's first library of adjuvants that can be ‘taken off the shelf’ and used to develop new epidemic and pandemic vaccines. Hosted by @MHRAgovuk, the $2.5m project will help developers select the best vaccine-adjuvant combinations: cepi.net/world-first-library…
The microbes inside us do more than digest food—they shape immunity, prevent disease, and may hold keys to the future of medicine.
At GHDDI, we’re committed to advancing global health through science—microbes included.
#Microbiome #GlobalHealth #GHDDI
Immunization saves lives.
Equity begins with access.
Join us this #WorldImmunizationWeek to support vaccines for all.
Together, we can make it happen.
#ImmunizationForAll #GlobalHealth #ImmunizationWeek
April 25 is #WorldMalariaDay.
Let’s reinvest, reimagine & reignite the fight to #EndMalaria.
At GHDDI, we’re advancing research on a novel single-dose antimalarial therapy—aiming to improve treatment & prevention.
Innovation matters. Hope drives action.
#GlobalHealth #Malaria
Dr. Chen Shuo, Senior Principal Investigator at GHDDI, shared insights on the latest #TB drug developments at the seminar hosted by Peking University’s CSMR, in collaboration with the GHDDI and the Gates Foundation, focused on accelerating China’s efforts to #EndTB. #WorldTBDay
Women have long been a force for change—breaking barriers and driving innovation. At GHDDI, our women scientists tackle #GlobalHealth challenges with passion and expertise. Today, we celebrate their impact and the power of women everywhere. Happy #InternationalWomensDay!
As a member of CARE Consortium, GHDDI is honored to have contributed to accelerating new therapies against SARS-CoV-2 and enhancing pandemic preparedness. While CARE concludes in March 2025, its legacy continues to shape #GlobalHealth. #CAREvsCOVID
loom.ly/pFPn_2Q
Wishing you a joyful Lantern Festival! May this season bring inspiration, collaboration, and breakthroughs. Innovation illuminates the path toward better health for all. #LanternFestival #GHDDI #GlobalHealth
As the #YearOfTheSnake arrives, we wish everyone a prosperous, healthy year filled with new opportunities and strength to overcome challenges!
As 2025 begins, GHDDI renews its mission to tackle neglected diseases and advance global health. Together with our partners, we’re turning hope into reality through innovation and collaboration. Here’s to a brighter, healthier future! #NewYear2025 #GlobalHealth
As the year ends, we reflect on a journey of innovation and collaboration at GHDDI, driving breakthroughs for #GlobalHealth. We are grateful to all who inspire innovation and change. Wishing everyone a #MerryChristmas and a healthier future!
New data from the World Malaria Report 2024 show a rise in malaria: 263M cases & 597K deaths in 2023, 95% in the WHO African Region. At GHDDI, we’re advancing antimalarial drug innovation to tackle rising resistance & save lives. #EndMalaria
Learn more: loom.ly/bsW1TZM
On #UHCDay2024, we highlight the urgent need to reduce the health and financial burden of disease. GHDDI drives innovative #DrugDiscovery, such as in TB and malaria to improve access to effective treatments, reduce the burden of disease, and promote #HealthForAll.
New research highlights urgent #AMR threat: artemisinin resistance in children with severe #malaria in Uganda. 10% of young patients showed delayed parasite clearance, signaling early resistance. Action is critical. #WAAW2024
Learn more⬇️loom.ly/FRuDSK8
The latest WHO report shows that #TB is once again the deadliest infectious disease, with 8.2 million new cases in 2023. Multidrug-resistant TB remains a public health crisis, with only 44% receiving diagnosis and treatment.
Learn more: loom.ly/IAD8qc8
Dr. Sheng Ding, Institute Director of @theGHDDI, was invited to attend the 3rd Global Development and Health Communication Forum hosted by @Tsinghua_Uni School of Journalism & Communication and shared insights on experiences and challenges of advocacy in #GlobalHealth.
On October 17, 2024, GHDDI officially established its Scientific Advisory Board (SAB) and held its first meeting. The SAB includes Dr. Manos Perros, Chairman, and board members Professor Wenhong Zhang, Dr. Yongjun Liu, Professor @Kelly_Chibale, and Professor Zhijian Chen.
The @gatesfoundation’s 2024 Goalkeepers Report highlights #malnutrition as a global child health crisis and calls for continued investment in vaccines and treatments.
⬇️ loom.ly/SZCeuNE
At @theGHDDI, we’re driven by purpose, not profit. This #InternationalDayofCharity, we celebrate the power of giving and collaboration in advancing #globalhealth. Together, we can turn scientific innovation into impactful solutions for those who need them most.
STAT’s recent report highlights the dedication behind RTS,S & R21 #malaria #vaccines. Despite challenges, researchers made groundbreaking strides. These vaccines symbolize hope and global collaboration!
Learn more ⬇️ loom.ly/VgqnlPU
